Brian J. Chernak, MD¹, Emily Coskun, MD^1*, Nina Orfali, MB, PhD², Yuqing Qiu, MS^3*, Rosemary Soave, MD^4*, Tsiporah B. Shore, MD², Koen van Besien, MD, PhD² and Mirella Salvatore, MD^4*

¹Department of Medicine, NewYork-Presbyterian Weill Cornell Medical Center, New York, NY
²Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY
³Division of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, NY
⁴Division of Infectious Diseases, Weill Cornell Medicine, New York, NY

Christopher Lemieux, MD¹, Lori Muffly, MD, MS², Sally Arai, MD, MS¹, Andrew R. Rezvani, MD¹, Surbhi Sidana, MD¹, Laura J. Johnston, MD¹, Wen-Kai Weng, MD, PhD¹, Parveen Shiraz, MD¹, Matthew J. Frank, MD, PhD¹, Everett H Meyer, MD, PhD^1*, Judith A Shizuru, MD, PhD¹, David B. Miklos, MD, PhD¹, Robert S. Negrin, MD¹ and Robert Lowsky, MD, FRCP¹

¹Stanford University School of Medicine, Stanford, CA
²Assistant Professor of Medicine, Stanford University School of Medicine, Stanford, CA

Issa F. Khouri, MD¹, Stephen K. Gruschkus, PhD, MPH^2*, Celina Ledesma^3*, Paolo Anderlini³, Qaiser Bashir^3*, May Daher⁴, Swami P. Iyer, MD⁵, David Marin¹, Rohtesh Mehta^3*, Amanda L. Olson⁴, Uday R. Popat, MD⁴, Felipe Samaniego, MD⁶, Muzaffar H. Qazilbash, MD^1,3, Jin S. Im⁴, Gabriela Rondon¹, Richard E. Champlin, MD¹, Alison Gulbis^7* and Ken H. Young⁸

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁴Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Pharmacy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁸Duke Medical Center and Duke Cancer institute, Duke University School of Medicine, Durham, NC

Onder Alpdogan, MD¹, Jennifer Hong, MD^2*, Thomas R. Klumpp, MD¹, Abdullateef O Abdulkareem, MD, MPH³, Adam F. Binder, MD¹, Matthew Carabasi, MD^1*, Joanne Filicko-O'Hara, MD^1*, Dolores Grosso, DNP, CRNP¹, Margaret Kasner, MD, MSc¹, Ubaldo Martinez-Outschoorn, MD^1*, Neil Palmisiano, MD, MS¹, Lindsay Wilde, MD¹, Pierluigi Porcu, MD¹, Usama Gergis, MD¹, John L. Wagner, MD^1* and Neal Flomenberg, MD¹

¹Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
²Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA
³Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA

Laure Vincent^1,2*, Luuk Gras Sr.^3*, Patrice Ceballos, MD, PhD^4*, Jürgen Finke Sr., MD, PhD⁵, Jakob Passweg^6*, Marie Robin, MD, PhD⁷, Laura Rosinol, MD, PhD^8*, Monique C. Minnema⁹, Raphael Teipel, MD^10*, JA Van Deosum^11*, Mathias Haenel, MD^12*, Pascal Lenain, MD^13*, Edouard Forcade, MD, PhD^14*, Christian Koenecke, MD^15*, Sophie Ducastelle, MD^16*, Jaime Sanz^17*, Wilfried Schroyens, MD, PhD¹⁸, Tsila Zuckerman, MD¹⁹, Marco Ladetto, MD²⁰, Linda Koster^21*, Liesbeth C. de Wreede, PhD^22*, Patrick J Hayden, MD²³, Stefan Schönland, MD^24*, Ibrahim Yakoub-Agha²⁵ and Meral Beksac, MD²⁶

¹CHU Montpellier, Montpellier, France
²Hôpital Saint-Eloi, Montpellier, France
³EBMT Statistical Unit, Leiden, Netherlands
⁴Department of Hematology, Hopital St Eloi CHU de Montpellier, Montpellier, France
⁵University of Freiburg, Freiburg, Germany, Dept. of Hematology, Oncology and Stem Cell Transplantation,, Freiburg, Germany
⁶University Hospital Basel, Basel, Switzerland
⁷Hôpital Saint-Louis, APHP, Paris, France
⁸Hematology, Hospital Clinic i Provincial, Barcelona, Spain
⁹University Medical Center Utrecht, Utrecht, Netherlands
¹⁰Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
¹¹University of Groningen, University Medical Center Groningen, Groningen, Netherlands
¹²Klinikum Chemnitz, Chemnitz, Germany
¹³Hematology department, Centre Henri Becquerel, Rouen, France
¹⁴Hôpital Haut-Levèque, Pessac, France
¹⁵Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
¹⁶Hematology department 1 G, Centre Hospitalier Lyon Sud, Pierre Benite, France
¹⁷Hospital Universitari I politècnic La Fe, VALENCIA, ESP
¹⁸Hematology, Antwerp University Hospital, Edegem, Belgium
¹⁹Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
²⁰Division of Hematology, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, ITA
²¹EBMT Data Office, Leiden, Netherlands
²²Leiden University Medical Center, Leiden, Netherlands
²³Department of Haematology, St. James's Hospital, Dublin, Ireland
²⁴University of Heidelberg, Heidelberg, Germany
²⁵Univ Lille, CHU de Lille, INFINITE, INSERM U1286, 59000 Lille, LILLE, France
²⁶Cebeci Yerleskesi Dikimevi, Ankara, Turkey

Elena Zamagni, MD^*, Cristina Nanni, MD^*, Francesca Gay, MD, Luca Dozza, MSc^*, Delia Rota Scalabrini^*, Mattia D'Agostino, MD^*, Rossella Ribolla, MD^*, Monica Galli^*, Manuela Racca, MD^*, Renato Zambello^*, Elena Rivolti, MD^*, Domenico Albano, MD^*, Annibale Versari, MD^*, Mariella Grasso^*, Rossella Troia, PharmD^*, Antonio Spadano^*, Francesca Patriarca^*, Marina Ruggeri^*, Marco Rensi, MD^*, Anna Pascarella^*, Pietro Zucchetta, MD^*, Paola Tacchetti^*, Stefano Fanti, MD, PhD^*, Mario Boccadoro, Michele Cavo^*, Pellegrino Musto and Stefania Oliva^*

GIMEMA, European Myeloma Network, Italy

Sachin Punatar^1,2*, Vinodhini Murugaiyan^1,2*, Anant Gokarn, MD, DM^1,2*, Akanksha Chichra, DNB^1,2*, Sumeet Prakash Mirgh, MD, DM^1,2*, Lingaraj Nayak, MD, DM^1,2*, Avinash Bonda, MD, DM^1,2*, Vijay Shirure, MD, DM^1,2*, Bhausaheb Bagal, MD, DM^1,2*, Libin J Mathew, BSc^3*, Sadhana Kannan, MSc^2,4*, Tapan Saikia, MD⁵ and Navin Khattry, MD, DM^1,2*

¹Bone Marrow Transplant Unit, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre., Navi Mumbai., India
²Homi Bhabha National Institute., Mumbai., India
³Bone Marrow Transplant Unit, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India
⁴Tata Memorial Centre., Department of biostatistics., Navi Mumbai., India
⁵Prince Aly Khan Hospital, Mumbai, India

Betul Oran, MD, MS¹, Gheath Alatrash², Amin M. Alousi, MD³, Rohtesh S. Mehta, MD, MPH, MS⁴, Chitra Hosing, MD², Uday R. Popat, MD⁴, Jin S. Im⁴, Jessica M McCarty, RN^2*, Jennifer D Ramos, RN^2*, Harold N. Keer, MD, PhD⁵, Peter F Thall, PhD^6* and Richard E. Champlin, MD²

¹Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, TX
²Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
³Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX
⁴Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Astex Pharmaceuticals Inc., Pleasanton, CA
⁶Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX

Perla R. Colunga Pedraza, MD¹, Julia Esther Colunga Pedraza, MD^2*, Andres Gomez-De Leon, MD¹, Mónica Bustillos Muñoz, MD^1*, Karen Lorena Osorno-Rodriguez, MD³, Jose Angel Hawing, MD¹, Oscar Gonzalez Llano, MD^2*, Yajaira Valentine Jimenez-Antolinez, MD^2*, Olga Graciela Cantu Rodriguez, MD^1*, Cesar Homero Gutierrez-Aguirre, PhD^1* and David Gomez-Almaguer, MD ¹

¹Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Servicio de Hematología, Monterrey, NL, Mexico
²Pediatric Hematology, Hospital Universitario Dr Jose E. Gonzalez UANL, Monterrey, NL, Mexico
³Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Servicio de Hematología, Monterrey, Mexico

Gi June Min, MD¹, Byung Sik Cho, M.D., Ph.D.^1*, Sung-Soo Park, M.D., Ph.D.^1*, Silvia Park, M.D, Ph.D.^1*, Seung-Ah Yahng, M.D., Ph.D.^2*, Young-Woo Jeon, MD, PhD^3*, Seung-Hwan Shin, MD^4*, Jae-Ho Yoon, M.D, Ph.D.^1*, Sung-Eun Lee, M.D, Ph.D.^1*, Ki-Seong Eom, M.D., Ph.D.^1*, Yoo-Jin Kim, M.D., Ph.D.¹, Chang-Ki Min, M.D, Ph.D.^1*, Seok-Goo Cho, M.D., Ph.D.^1*, Dong-Wook Kim, MD¹, Jong Wook Lee, M.D., Ph.D.⁵, Heeje Kim, MD, PhD¹ and Seok Lee, M.D., Ph.D.¹

¹Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Seoul, Korea, Republic of (South)
²Department of Hematology, Incheon St Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea, Incheon, Korea, Republic of (South)
³Department of Hematology, Yeouido St. Mary's Hematology Hospital, The Catholic University of Korea, College of Medicine, Seoul, Korea, Republic of (South), Seoul, Korea, Republic of (South)
⁴The Catholic University of Korea, College of Medicine, Eunpyeong St. Mary’s Hospital, Department of Hematology, Seoul, Korea, Republic of (South)
⁵Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)